Europe Nicotinamide Mononucleotide NMN
Market Report
2025
Delivery Includes:- Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Europe Nicotinamide Mononucleotide NMN Market Report 2023.
According to Cognitive Market Research, the global Nicotinamide Mononucleotide NMN market size was estimated at USD 115.9 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 34.77million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.5%from 2024 to 2031.
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Europe Nicotinamide Mononucleotide NMN Market Sales Revenue 2021 | $ 55.7 Million |
Europe Nicotinamide Mononucleotide NMN Market Sales Revenue 2024 | $ 34.77 Million |
Europe Nicotinamide Mononucleotide NMN Market Sales Revenue 2025 | $ 75.2 Million |
Europe Nicotinamide Mononucleotide NMN Market Compound Annual Growth Rate (CAGR) for 2023 to 2030 | 7.7% |
Market Split by Product Form |
|
Market Split by Application |
|
Market Split by Distribution Channel |
|
List of Competitors | Competitors not disclose (Request Sample) |
Country Analysis | United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Rest of Europe | Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Europe Nicotinamide Mononucleotide NMN industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Europe Nicotinamide Mononucleotide NMN Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
In Europe, the Nicotinamide Mononucleotide (NMN) market has witnessed substantial growth driven by increasing health consciousness and aging demographics. The region's proactive approach towards health and wellness has bolstered demand for NMN, particularly in applications aimed at promoting anti-aging benefits. The anti-aging segment stands out as a key driver within Europe's NMN market, supported by a growing preference for natural supplements and longevity-promoting solutions. Consumers are increasingly seeking products that offer metabolic health benefits and support athletic performance, reflecting a broader trend towards holistic health management. This trend underscores Europe's role as a burgeoning market for innovative NMN formulations catering to diverse health needs.
Read a Detailed Qualitative analysis of the above report by requesting the free sample pages from Request for your Free Sample PDF/Online Access.
The NMN market features a competitive landscape characterized by a mix of established players and emerging entrants focusing on product innovation and market expansion. Key players such as ChromaDex Corporation, Elysium Health, and ProHealth Longevity are prominent in the market, leveraging their research capabilities and brand recognition to maintain market dominance.
December 2021: Novo Nordisk acquired Dicerna Pharmaceuticals. With the completion of the merger, Dicerna became a wholly-owned subsidiary of Novo Nordisk. The common stock of Dicerna will not be disclosed on listed or traded on the Nasdaq Global Select Market. (Source: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=93736) October 2022: the dietary supplement expert ChromaDex (NR). The results showed that NR could increase NAD+ levels, making it an innovative treatment for heart failure with a lower ejection fraction. (Source: https://www.ahajournals.org/doi/10.1161/circulationaha.116.026099)
Top Companies Market Share in Europe Nicotinamide Mononucleotide NMN Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The published report edition delivers Europe Market size analysis from 2021 till the forecast period of 2031. We have included analysis of top performing countries such as (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Rest of Europe) and their Market segmentation by Product Form, Application, Distribution Channel, etc. This will help you to understand detailed segment profile, revenue generation, growth patterns, trends, and differences among the each segments.
Europe Nicotinamide Mononucleotide NMN market Product Form size and share analysis, have been revealed under this section. This section offers market size, revenue share, y-o-y growth rate along with market attractiveness for each type. This will help you to understand which type held largest revenue share along with its compound annual growth rate (CAGR) of Europe Nicotinamide Mononucleotide NMN Market.
With the help of type segment analysis, companies can understand which type has potential to invest along with its driving factors, current trends and other key factors. The timeline covered in the published North America Report edition is 2021 to 2033.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
Application segment analysis is key parameter for key companies and new entrants offering versatile products or services, helping them customize products to meet the need of different user scenarios. Based on the application segment analysis, key companies can choose which application segments to target in the Europe Nicotinamide Mononucleotide NMN Market. Our experts continuously monitor market dynamics and consumer trends of the each application to evaluate the attractiveness and potential of each segment. In terms of revenue, we can also provide the cross split of types in the each application for year 2021-2033. To understand more please connect with our sales team.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
The Current Published report Editon on the website includes the following list of countries analysis whereas in case you looking to access any other country or states level data under Europe then please revert us to access the exclusive Europe Nicotinamide Mononucleotide NMN industry report Edition.
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.Senior Research Analyst at Cognitive Market Research
• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.
Manoj Phagare is a dynamic and results-driven research analyst with a passion for transform...Read More
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Europe Nicotinamide Mononucleotide NMN Market is witnessing significant growth in the near future.
In 2023, the Capsules/Pills segment accounted for noticeable share of Europe Nicotinamide Mononucleotide NMN Market and is projected to experience significant growth in the near future.
The Anti-Aging segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies , and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Table of Content differs accordign to the user License selction. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section's Or chapter's from the report. Specific section's of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Product Form | Capsules/Pills, Powder, Liquid |
Application | Anti-Aging, Metabolic Health, Athletic Performance, Others |
Distribution Channel | Online Retail, Offline Retail |
List of Competitors | Not Disclosed! Request To Preview the List |
This chapter will help you gain Europe Market Analysis of Europe Nicotinamide Mononucleotide NMN. Further deep in this chapter, you will be able to review Europe Europe Nicotinamide Mononucleotide NMN Market Split by various segments and Country Split.
Chapter 1 Europe Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Europe Nicotinamide Mononucleotide NMN. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 2 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 3 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Form Analysis 2019 -2031, will provide market size split by Product Form. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 4 Market Split by Product Form Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 5 Market Split by Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 6 Market Split by Distribution Channel Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Europe Nicotinamide Mononucleotide NMN market
Chapter 7 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Capsules/Pills have a significant impact on Europe Nicotinamide Mononucleotide NMN market? |
What are the key factors affecting the Capsules/Pills and Powder of Europe Nicotinamide Mononucleotide NMN Market? |
What is the CAGR/Growth Rate of Anti-Aging during the forecast period? |
By type, which segment accounted for largest share of the Europe Nicotinamide Mononucleotide NMN Market? |
Which region is expected to dominate the Europe Nicotinamide Mononucleotide NMN Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|